Corrigendum: Preference for Novel Biomedical HIV Pre-exposure Prophylaxis Methods among Adolescent Girls and Young Women in Kampala, Uganda: A Mixed Methods Study

Yunia Mayanja ^1,2* Ivy Kayesu ¹ Onesmus Kamacooko ³ Jane Frances Lunkuse ¹ Vincent Muturi-Kioi ⁴ Matt Price ^5,6 Kyriaki Kosidou ^2,7 Anna Mia Ekström ^2,8,9

• ¹ London School of Hygiene and Tropical Medicine Uganda Research Unit, Medical Research Council (Uganda), Entebbe, Uganda
• ² Department of Global Public Health, Karolinska Institutet (KI), Stockholm, Stockholm, Sweden
• ³ School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda
• ⁴ IAVI, Nairobi, Kenya
• ⁵ International AIDS Vaccine Initiative Inc, New York, New York, United States
• ⁶ University of California, San Francisco, San Francisco, California, United States
• ⁷ Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden
• ⁸ Department of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm, Stockholm, Sweden
• ⁹ Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet (KI), Stockholm, Stockholm, Sweden

Corrigendum on: Mayanja Y, Kayesu I, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Price M, Kosidou K and Ekström AM (2024) Preference for novel biomedical HIV pre-exposure prophylaxis methods among adolescent girls and young women in Kampala, Uganda: a mixed methods study. Front. Public Health 12:1369256. doi: 10.3389/fpubh.2024.1369256. In the published article, there was an error in the Funding statement. The project code for the EDCTP funder was erroneously written as "3120" instead of "3102" and we listed project activities funded rather than use the generic funder statement. The original text is, "The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by IAVI and made possible by the support of many donors including United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. IAVI also sponsored the study and therefore contributed to the study design, monitored the study and, representatives reviewed and approved all versions of the manuscript. The East Africa Consortium for Clinical Research / 736 EACCR3 (CSA2020NoE-3120) under the European and Developing Countries Clinical Trials 737 Partnership (EDCTP2) provided funding for travel and supervision of this work as part of doctoral 738 studies at Karolinska institute".The correct Funding statement appears below. "The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was funded by IAVI and made possible by the support of many donors including United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. IAVI also sponsored the study and therefore contributed to the study design, monitored the study and, representatives reviewed and approved all versions of the manuscript. This project is part of the EDCTP2 program supported by the European Union (CSA2020NoE-3102). The views and opinions of authors expressed herein do not necessarily state or reflect those of EDCTP". The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.